Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma
D. Price (Singapore, Singapore), S. Burkill (Singapore, Singapore), E. Wang (Denver, United States), M. E. Wechsler (Denver, United States), E. Denton (Melbourne, Australia), T. N.Tran (Gaithersburg, United States), N. Martin (Gaithersburg, United States), R. Katial (Gaithersburg, United States), P. Barker (Gaithersburg, United States), J. Maspero (Buenos Aires , Argentina), M. Hew (Melbourne, Australia), G. Bruselle (Ghent, Belgium), G. C Christoff (Sofia, Bulgaria), M. Sadatsafavi (Vancouver, Canada), C. A. Torres-Duque (Bogotá, Colombia), C. M. Porsbjerg (Bispebjerg, Denmark), C. Ulrik (Hvidovre, Denmark), S. Hansen (Copenhagen, Denmark), A. Altraja (Tartu, Estonia), A. Bourdin (Montpellier, France), N. G. Papadopoulos (Athens, Greece), K. Kostikas (Ioannina, Greece), S. Salvi (Pune, India), R. W Costello (Dublin , Ireland), P. Francesca (Rozzano, Italy), T. Iwanga (Osakasayama, Japan), C. Kook Rhee (Seoul, Republic of Korea), M. Al-Ahmad (Kuwait , Kuwait), D. Larenas Linnemann (Ciudad de México, Mexico), J. A Fonseca (Porto, Portugal), B. G.Cosio (Mallorca, Spain), M. Koh Siyue (Singapore , Singapore), B. Kirenga (Kampala , Uganda), C. Sheu (Taiwan, Taiwan), M. Tsai (Taiwan, Taiwan), B. Mahboub (Sharjaha, United Arab Emirates), J. Busby (Belfast, United Kingdom), L. G Heaney (Belfast, United Kingdom), P. E Pfeffer (London, United Kingdom), P. Patel (London, United Kingdom), F. Hoyte (Colorado , United States), Y. Liu (Brisbane, Australia), C. Goh (Singapore, Singapore), J. Lyu (Singapore, Singapore), T. Uthaman (Singapore, Singapore), W. Henley (Singapore, Singapore), W. Henley (United Kingdom)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4323
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Price (Singapore, Singapore), S. Burkill (Singapore, Singapore), E. Wang (Denver, United States), M. E. Wechsler (Denver, United States), E. Denton (Melbourne, Australia), T. N.Tran (Gaithersburg, United States), N. Martin (Gaithersburg, United States), R. Katial (Gaithersburg, United States), P. Barker (Gaithersburg, United States), J. Maspero (Buenos Aires , Argentina), M. Hew (Melbourne, Australia), G. Bruselle (Ghent, Belgium), G. C Christoff (Sofia, Bulgaria), M. Sadatsafavi (Vancouver, Canada), C. A. Torres-Duque (Bogotá, Colombia), C. M. Porsbjerg (Bispebjerg, Denmark), C. Ulrik (Hvidovre, Denmark), S. Hansen (Copenhagen, Denmark), A. Altraja (Tartu, Estonia), A. Bourdin (Montpellier, France), N. G. Papadopoulos (Athens, Greece), K. Kostikas (Ioannina, Greece), S. Salvi (Pune, India), R. W Costello (Dublin , Ireland), P. Francesca (Rozzano, Italy), T. Iwanga (Osakasayama, Japan), C. Kook Rhee (Seoul, Republic of Korea), M. Al-Ahmad (Kuwait , Kuwait), D. Larenas Linnemann (Ciudad de México, Mexico), J. A Fonseca (Porto, Portugal), B. G.Cosio (Mallorca, Spain), M. Koh Siyue (Singapore , Singapore), B. Kirenga (Kampala , Uganda), C. Sheu (Taiwan, Taiwan), M. Tsai (Taiwan, Taiwan), B. Mahboub (Sharjaha, United Arab Emirates), J. Busby (Belfast, United Kingdom), L. G Heaney (Belfast, United Kingdom), P. E Pfeffer (London, United Kingdom), P. Patel (London, United Kingdom), F. Hoyte (Colorado , United States), Y. Liu (Brisbane, Australia), C. Goh (Singapore, Singapore), J. Lyu (Singapore, Singapore), T. Uthaman (Singapore, Singapore), W. Henley (Singapore, Singapore), W. Henley (United Kingdom). Biomarker-defined clusters by level of Type 2 inflammatory involvement in severe asthma. 4323
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|